P

Inventor

HE CHUNHONG

US75 patents
⚠️ This page may combine multiple inventors who share the name “HE CHUNHONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INCYTE CORP

42 patents
US7767675B2Aug 3, 2010

Imidazotriazines and imidazopyrimidines as kinase inhibitors

INCYTE CORP85 citations99
US10450313B2Oct 22, 2019

Bicyclic heterocycles as FGFR inhibitors

INCYTE CORP32 citations98
US10131667B2Nov 20, 2018

Substituted tricyclic compounds as FGFR inhibitors

INCYTE CORP35 citations98
US10040790B2Aug 7, 2018

Bicyclic heterocycles as FGFR inhibitors

INCYTE CORP36 citations98
US9611267B2Apr 4, 2017

Substituted tricyclic compounds as FGFR inhibitors

INCYTE CORP54 citations98
US9533954B2Jan 3, 2017

Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

INCYTE CORP42 citations98
US9533984B2Jan 3, 2017

Bicyclic heterocycles as FGFR inhibitors

INCYTE CORP42 citations98
US7776874B2Aug 17, 2010

Amido compounds and their use as pharmaceuticals

INCYTE CORP27 citations96
US7304081B2Dec 4, 2007

Amido compounds and their use as pharmaceuticals

INCYTE CORP42 citations96
US11053246B2Jul 6, 2021

Substituted tricyclic compounds as FGFR inhibitors

INCYTE CORP23 citations94
US10813930B2Oct 27, 2020

Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

INCYTE CORP27 citations94
US10213427B2Feb 26, 2019

Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

INCYTE CORP34 citations94
US10174030B2Jan 8, 2019

Cyclopropylamines as LSD1 inhibitors

INCYTE CORP14 citations94
US10092570B2Oct 9, 2018

Heterocyclylamines as PI3K inhibitors

INCYTE CORP17 citations94
US9981975B2May 29, 2018

Pyrrolotriazine compounds as tam inhibitors

INCYTE CORP18 citations94
US9944647B2Apr 17, 2018

Heterocyclic compounds as LSD1 inhibitors

INCYTE CORP30 citations94
US9745311B2Aug 29, 2017

Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors

INCYTE CORP45 citations94
US9730939B2Aug 15, 2017

Heterocyclylamines as PI3K inhibitors

INCYTE CORP23 citations94
US9695180B2Jul 4, 2017

Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors

INCYTE CORP24 citations94
US9695168B2Jul 4, 2017

Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors

INCYTE CORP27 citations94
US9670210B2Jun 6, 2017

Cyclopropylamines as LSD1 inhibitors

INCYTE CORP23 citations94
US9527835B2Dec 27, 2016

Cyclopropylamines as LSD1 inhibitors

INCYTE CORP25 citations94
US9493442B2Nov 15, 2016

Cyclopropylamines as LSD1 inhibitors

INCYTE CORP30 citations94
US9493450B2Nov 15, 2016

Cyclopropylamines as LSD1 inhibitors

INCYTE CORP26 citations94
US9388185B2Jul 12, 2016

Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors

INCYTE CORP44 citations94
US9221824B2Dec 29, 2015

Imidazo[1,2-B][1,2,4]triazines as c-Met inhibitors

INCYTE CORP14 citations93
US10053465B2Aug 21, 2018

Pyrrolopyrimidine derivatives as TAM inhibitors

INCYTE CORP16 citations92
US11840534B2Dec 12, 2023

Substituted tricyclic compounds as FGFR inhibitors

INCYTE CORP4 citations86
US11591338B2Feb 28, 2023

Pyrrolotriazine compounds as TAM inhibitors

INCYTE CORP5 citations86
US11530214B2Dec 20, 2022

Bicyclic heterocycles as FGFR inhibitors

INCYTE CORP7 citations86
US10300051B2May 28, 2019

Cyclopropylamines as LSD1 inhibitors

INCYTE CORP14 citations86
US11433071B2Sep 6, 2022

Heterocyclylamines as PI3K inhibitors

INCYTE CORP3 citations84
US11136326B2Oct 5, 2021

Pyrrolopyrimidine derivatives as TAM inhibitors

INCYTE CORP6 citations84
US10844069B2Nov 24, 2020

Pyrrolotriazine compounds as TAM inhibitors

INCYTE CORP9 citations84
US10800779B2Oct 13, 2020

Heterocyclic compounds as LSD1 inhibitors

INCYTE CORP6 citations84
US10717737B2Jul 21, 2020

Cyclopropylamines as LSD1 inhibitors

INCYTE CORP7 citations84
US10640503B2May 5, 2020

Imidazopyridines and imidazopyrazines as LSD1 inhibitors

INCYTE CORP7 citations84
US10556908B2Feb 11, 2020

Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors

INCYTE CORP8 citations84
US10442810B2Oct 15, 2019

Pyrrolotriazine compounds as TAM inhibitors

INCYTE CORP12 citations84
US10112950B2Oct 30, 2018

Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors

INCYTE CORP15 citations84
US9957229B2May 1, 2018

Amido compounds and their use as pharmaceuticals

INCYTE CORP4 citations84
US11673894B2Jun 13, 2023

Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors

INCYTE CORP4 citations74

YAO WENQING

3 patents

INCYTE HOLDINGS CORP

3 patents

ZHUO JINCONG

2 patents

Showing the top 50 of 75 patents by PatentIndex Score.